Quest Diagnostics
DGX
$134.55
Share price
-0.83%
Change (1 day)
2.51%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Quest Diagnostics (DGX) - Cash on Hand
Cash on Hand as of March 2023 : $0.17 B
According to Quest Diagnostics
's latest financial reports the company has $0.17 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Quest Diagnostics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.31 B | -63.88% |
| 2021-12-31 | $0.87 B | -24.7% |
| 2020-12-31 | $1.15 B | -2.85% |
| 2019-12-31 | $1.19 B | 782.96% |
| 2018-12-31 | $0.13 B | -1.46% |
| 2017-12-31 | $0.13 B | -61.84% |
| 2016-12-31 | $0.35 B | 169.92% |
| 2015-12-31 | $0.13 B | -30.73% |
| 2014-12-31 | $0.19 B | 2.67% |
| 2013-12-31 | $0.18 B | -36.74% |
| 2012-12-31 | $0.29 B | 79.27% |
| 2011-12-31 | $0.16 B | -63.3% |
| 2010-12-31 | $0.44 B | -15.9% |
| 2009-12-31 | $0.53 B | 110.38% |
| 2008-12-31 | $0.25 B | 51.52% |
| 2007-12-31 | $0.16 B | 12% |
| 2006-12-31 | $0.14 B | 62.42% |
| 2005-12-31 | $92.13 M | 25.69% |
| 2004-12-31 | $73.3 M | -52.7% |
| 2003-12-31 | $0.15 B | 60.12% |
| 2002-12-31 | $96.77 M | -20.89% |
| 2001-12-31 | $0.12 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 LabCorp LH | $0.39 B | 125.09% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 Psychemedics PMD | $4.75 M | -97.29% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.43 B | 150.28% | 🇺🇸 USA |
 Qiagen QGEN | $1.41 B | 710.44% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $5.05 M | -97.11% | 🇺🇸 USA |